This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Badimon, L. Articles by Fuster, V. Search for Related Content PubMed PubMed Citation Articles by Badimon, L. Articles by Fuster, V.

Circulation, Vol 78, 1431-1442, Copyright © 1988 by American Heart Association

ARTICLES

Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation

L Badimon, JJ Badimon, VT Turitto, S Vallabhajosula and V Fuster
Division of Cardiology, Mount Sinai Medical Center, New York, NY 10029.

Collagen type I is a major component of atherosclerotic vessel wall that is exposed on deep vessel injury, such as in balloon angioplasty or plaque rupture. Collagen type I from pig Achilles tendon was mounted in a tubular perfusion chamber placed within an extracorporeal circuit (carotid artery to jugular vein). The material was exposed to blood from normal pigs (n = 13), severe homozygous von Willebrand factor (vWF)-deficient pigs (vWF less than 3%) (n = 6), and heterozygous vWF- deficient pigs (vWF = 24%) (n = 2). Thrombus formation was measured by autologous 111In-platelet labeling and by ultrastructural morphology. Heparinized and native blood from these pigs was perfused over the substrate for 3 and 5 minutes at local shear rates from 212 to 3,380/sec. On collagen type I exposed to nonanticoagulated blood, for all exposure times studied, thrombus formation in the absence of vWF was significantly reduced at high shear rate typical of stenotic areas but not at low shear rate typical of unobstructed medium-size arteries. A similar inhibition in thrombus formation due to vWF deficiency was observed in both heparinized and native blood; however, thrombus formation was significantly more reduced (p less than 0.05) in the presence of heparin, presumably due to the lack of stability of the accumulated platelets in the absence of fibrin formation. Intermediate levels of vWF, as in heterozygous von Willebrand's disease (vWD), support platelet deposition to extents not significantly different from normal conditions. Therefore, on collagen type I, both the activation of blood coagulation proteins and the presence of vWF contribute significantly to the platelet-platelet interactions necessary for thrombus formation. The effect of vWF occurs primarily at high shear conditions typical intravascularly of flow at the apex of advanced stenotic lesions; thus, these findings may suggest that the absence of vWF may be protective against the development of acute thrombosis in these regions.

This article has been cited by other articles:

				J. J. Hathcock Flow Effects on Coagulation and Thrombosis Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1729 - 1737. [Abstract] [Full Text] [PDF]

				M. M. Wahidi, R. Garland, D. Feller-Kopman, F. Herth, H. D. Becker, and A. Ernst Effect of Clopidogrel With and Without Aspirin on Bleeding Following Transbronchial Lung Biopsy Chest, March 1, 2005; 127(3): 961 - 964. [Abstract] [Full Text] [PDF]

				P. Andre, T. LaRocca, S. M. Delaney, P. H. Lin, D. Vincent, U. Sinha, P. B. Conley, and D. R. Phillips Anticoagulants (Thrombin Inhibitors) and Aspirin Synergize With P2Y12 Receptor Antagonism in Thrombosis Circulation, November 25, 2003; 108(21): 2697 - 2703. [Abstract] [Full Text] [PDF]

				D. Patel, H. Vaananen, M. Jirouskova, T. Hoffmann, C. Bodian, and B. S. Coller Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy Blood, February 1, 2003; 101(3): 929 - 936. [Abstract] [Full Text] [PDF]

				D. A. Brickey and D. P. Lawlor Transbronchial Biopsy in the Presence of Profound Elevation of the International Normalized Ratio Chest, June 1, 1999; 115(6): 1667 - 1671. [Abstract] [Full Text] [PDF]

				B. J. Meyer, J. J. Badimon, J. H. Chesebro, J. T. Fallon, V. Fuster, and L. Badimon Dissolution of Mural Thrombus by Specific Thrombin Inhibition With r-Hirudin : Comparison With Heparin and Aspirin Circulation, February 24, 1998; 97(7): 681 - 685. [Abstract] [Full Text] [PDF]

				B. Kehrel, S. Wierwille, K. J. Clemetson, O. Anders, M. Steiner, C. Graham Knight, R. W. Farndale, M. Okuma, and M. J. Barnes Glycoprotein VI Is a Major Collagen Receptor for Platelet Activation: It Recognizes the Platelet-Activating Quaternary Structure of Collagen, Whereas CD36, Glycoprotein IIb/IIIa, and von Willebrand Factor Do Not Blood, January 15, 1998; 91(2): 491 - 499. [Abstract] [Full Text] [PDF]

				W. F. Baker JR Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I) Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 51 - 75. [Abstract] [PDF]

				K. Kaikita, H. Ogawa, H. Yasue, M. Takeya, K. Takahashi, T. Saito, K. Hayasaki, K. Horiuchi, A. Takizawa, Y. Kamikubo, et al. Tissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2232 - 2237. [Abstract] [Full Text]

				V. Toschi, R. Gallo, M. Lettino, J. T. Fallon, S. D. Gertz, A. Fernandez-Ortiz, J. H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, et al. Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques Circulation, February 4, 1997; 95(3): 594 - 599. [Abstract] [Full Text]

				G. Montalescot, A. Ankri, E. Vicaut, G. Drobinski, Y. Grosgogeat, and D. Thomas Fibrinogen After Coronary Angioplasty as a Risk Factor for Restenosis Circulation, July 1, 1995; 92(1): 31 - 38. [Abstract] [Full Text]